tradingkey.logo
搜索

NovaBay Pharmaceuticals Inc

NBY
添加自选
1.950USD
0.0000.00%
收盘 05/15, 16:00美东报价延迟15分钟
43.67M总市值
亏损市盈率 TTM

NovaBay Pharmaceuticals Inc

1.950
0.0000.00%

关于 NovaBay Pharmaceuticals Inc 公司

NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

NovaBay Pharmaceuticals Inc简介

公司代码NBY
公司名称NovaBay Pharmaceuticals Inc
上市日期Oct 26, 2007
CEOKazley (Michael John)
员工数量14
证券类型Ordinary Share
年结日Oct 26
公司地址2000 Powell St Ste 1150
城市EMERYVILLE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编94608-1804
电话15108998800
网址https://novabay.com/
公司代码NBY
上市日期Oct 26, 2007
CEOKazley (Michael John)

NovaBay Pharmaceuticals Inc公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--

收入明细

FY2025Q3
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
521.00K
0.00%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 5月14日 周四
更新时间: 5月14日 周四
持股股东
股东类型
持股股东
持股股东
占比
R01 Fund LP
42.67%
Framework Ventures Management LLC
42.67%
Lazar (David Elliot)
4.80%
BlackRock Institutional Trust Company, N.A.
1.38%
Vanguard Capital Management, LLC
1.02%
其他
7.46%
持股股东
持股股东
占比
R01 Fund LP
42.67%
Framework Ventures Management LLC
42.67%
Lazar (David Elliot)
4.80%
BlackRock Institutional Trust Company, N.A.
1.38%
Vanguard Capital Management, LLC
1.02%
其他
7.46%
股东类型
持股股东
占比
Corporation
85.34%
Individual Investor
4.80%
Investment Advisor
3.05%
Investment Advisor/Hedge Fund
1.40%
Hedge Fund
0.81%
Research Firm
0.15%
Pension Fund
0.02%
其他
4.43%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
47
1.80M
6.77%
+1.46M
2025Q4
41
3.14M
2.49%
+1.61M
2025Q3
38
1.37M
22.81%
-82.54K
2025Q2
43
1.43M
24.52%
+210.59K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
R01 Fund LP
11.36M
42.67%
--
--
Feb 09, 2026
Framework Ventures Management LLC
11.36M
42.67%
--
--
Feb 09, 2026
Lazar (David Elliot)
1.28M
4.8%
--
--
Jan 29, 2026
BlackRock Institutional Trust Company, N.A.
366.15K
1.38%
+366.15K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
251.54K
0.94%
+241.20K
+2331.76%
Dec 31, 2025
Poplar Point Capital Management LLC
204.06K
0.77%
--
--
Nov 04, 2025
Jane Street Capital, L.L.C.
14.01K
0.05%
+14.01K
--
Dec 31, 2025
State Street Investment Management (US)
62.74K
0.24%
+56.88K
+970.48%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Feb 12, 2026
Merger
5→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
公告日期
除权除息日
类型
比率
Feb 12, 2026
Merger
5→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
KeyAI